Finance

Lists
ABEO:NASDAQ
Abeona Therapeutics Inc
$5.08
+1.40%
(+0.070) 1D
$5.05
-0.59% (-0.030)
After hours
Closed: Oct 7, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ABEO...
Open
$4.95
High
$5.10
Low
$4.93
Mkt. cap
290.49M
Avg. vol.
1.32M
Volume
27.00
52-wk high
$7.65
52-wk low
$4.00
EPS
-$1.12
Beta
1.31
Shares outstanding
57.18M
No. of employees
226
Open
$4.95
High
$5.10
Low
$4.93
Mkt. cap
290.49M
Avg. vol.
1.32M
Volume
27.00
52-wk high
$7.65
52-wk low
$4.00
EPS
-$1.12
Beta
1.31
Shares outstanding
57.18M
No. of employees
226
News stories
From web sources and news partners
About Abeona Therapeutics Inc
CEO-
Employees226
Founded1974
HeadquartersCleveland, Ohio, United States
SectorBiotechnology
Websiteabeonatherapeutics.com
Analyst ratings
Based on 4 analysts giving stock ratings to ABEO in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ABEO in the last 3 months.
Highest
Current $5.08
$30.00 (+490.55%)
Average
$22.00 (+333.07%)
Lowest
$17.00 (+234.65%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$20.00
+293.7%
09/25/2026
Kristen Kluska
Cantor Fitzgerald
Buy
Maintained
$30.00
+490.6%
09/17/2026
Boobalan Pachaiyappan
Roth MKM
Buy
Initiated
$17.00
+234.6%
09/19/2026
Unknown Analyst
Oppenheimer
Buy
Reiterated
$21.00
+313.4%
08/14/2026
Unknown Analyst
Jefferies
Buy
Maintained
$17.00
+234.6%
05/14/2026
James Molloy
Alliance Global Partners
Buy
Reiterated
$20.00
+293.7%
05/13/2026
Stephen Willey
Stifel Nicolaus
Buy
Maintained
$17.00
+234.6%
03/18/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
5.42M
8.72M
11.38M
Cost of goods sold
4.70M
9.55M
12.25M
9.20M
Cost of revenue
4.70M
9.55M
12.25M
9.20M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19.31M
18.78M
19.50M
15.84M
Operating expense
19.31M
18.78M
19.50M
15.84M
Total operating expenses
24.02M
28.33M
31.75M
25.03M
Operating income
-24.02M
-22.91M
-23.03M
-13.65M
Other non operating income
2.89M
1.57M
5.44M
-7.20M
EBT including unusual items
-20.36M
-20.68M
-17.07M
-20.19M
EBT excluding unusual items
-20.36M
-20.68M
-17.07M
-20.19M
Income tax expense
-15.20M
-215.00K
2.00K
-
Effective tax rate
74.65%
1.04%
-0.01%
-
Other operating expenses
-
-
-
-
Net income
-5.16M
-20.46M
-17.08M
-20.19M
Net profit margin
-
-377.49%
-195.81%
-177.43%
Earnings per share
-0.11
-0.37
-0.30
-0.35
Interest and investment income
1.67M
1.55M
1.35M
1.36M
Interest expense
-901.00K
-884.00K
-830.00K
-696.00K
Net interest expenses
771.00K
663.00K
524.00K
659.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-23.41M
-22.05M
-22.34M
-12.99M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps